SUSTIVA
- Product NDC
- 0056-0474
- 11-digit product format
- 000560474
- Labeler code
- 0056
- Product ID
- 0056-0474_41a64d5a-31b4-47ba-b508-83ad0aa316f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- efavirenz
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- Bristol-Myers Squibb Pharma Company
- Application
- NDA020972
- Marketing category
- NDA
- Marketing start
- 1998-09-17
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0056-0474-92 | 00056047492 | 90 CAPSULE, GELATIN COATED in 1 BOTTLE (0056-0474-92) | 1998-09-17 | 0000-00-00 | No | No | Current |